Definitive healthcare corp. reports inducement grants under nasdaq listing rule 5635(c)(4)

Framingham, mass., march 04, 2025 (globe newswire) -- definitive healthcare (nasdaq: dh), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of two senior leaders, the human capital management and compensation committee (the “committee”) of definitive healthcare's board of directors granted inducement awards. the committee granted kate hastings, definitive healthcare's new chief customer officer an inducement award consisting of 172,414 time-based restricted stock units (“rsus”) effective march 3, 2025 and granted benjamin graboske, definitive healthcare's new evp, technology, engineering and chief data officer an inducement award consisting of 1,018,330 time-based rsus, effective march 3, 2025. each of these awards was individually negotiated and was granted as an inducement material to ms. hastings' and mr. graboske's respective commencement of employment with definitive healthcare in accordance with nasdaq listing rule 5635(c)(4).
NDAQ Ratings Summary
NDAQ Quant Ranking